This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Cellink Bioprinting Ab. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Michela Schettino: Innovator in 3D Bioprinting Bioinks
Introduction
Michela Schettino is a pioneering inventor based in Sperone, Italy. She has made significant contributions to the field of bioprinting, particularly in the development of bioinks for bone repair. Her innovative work focuses on utilizing cellulose nanofibrils and calcium phosphate particles to create effective solutions for bone defects.
Latest Patents
Michela holds a patent titled "Preparation and applications of 3D bioprinting bioinks for repair of bone defects, based on cellulose nanofibrils hydrogels with natural or synthetic calcium phosphate particles." This invention involves a bioink composed of cellulose nanofibril hydrogel combined with calcium-containing particles. The concentration of these particles can range from 1% to 40% w/v. The bioink can be 3D bioprinted with or without human or animal cells, allowing for versatile applications in medical treatments.
Career Highlights
Michela is currently associated with Cellink Bioprinting AB, a company known for its advancements in bioprinting technology. Her work has led to the creation of constructs that exhibit high porosity, excellent mechanical properties, and the ability to promote vascularization, which is essential for effective bone healing. The bioinks developed by Michela are designed to be easily handled and printed, making them suitable for patient-specific applications.
Collaborations
Michela has collaborated with notable colleagues in her field, including Paul Gatenholm and Hector Martinez. Their combined expertise has contributed to the advancement of bioprinting technologies and the development of innovative solutions for medical applications.
Conclusion
Michela Schettino's contributions to the field of 3D bioprinting bioinks represent a significant advancement in medical technology. Her innovative approach to creating bioinks for bone repair showcases the potential of bioprinting in improving patient outcomes.